Sulforaphane-rich Broccoli Sprout Extract for Schizophrenia
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Positive and Negative Syndrome Scale (PANSS)
研究概览
简要总结
Accumulating evidence suggests a role of oxidative stress in the pathophysiology of schizophrenia. The potent antioxidant sulforaphane (SFN) is an organosulfur compound derived from a glucosinolate precursor found in cruciferous vegetables such as broccoli, Brussels sprouts and cabbage. The protection afforded by SFN is thought to be mediated via activation of the NF-E2-related factor-2 (Nrf2) pathway and subsequent up-regulation of phase II detoxification enzymes and antioxidant proteins, through an enhancer sequence referred to as the electrophilic responsive element or antioxidant responsive element. Recently, we reported that SFN could attenuate behavioral abnormalities in mice after the NMDA receptor antagonist phencyclidine. Considering the potent antioxidant effects of SFN, we have a hypothesis that SFN would be a potential therapeutic drug for schizophrenia. The purpose of this study is to determine whether SFN-rich broccoli sprout extract have beneficial effects in patients with schizophrenia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Schizophrenia for DSM-IV TR criteria
- •Patients are treated with an antipsychotic drug (risperidone, olanzapine, quetiapine, perospirone, aripiprazole, blonanserin, paliperidone).
- •Patients are stable for 4-weeks for antipsychotic medication.
排除标准
- •Patients treated with clozapine
- •Patients treated with two or more antipsychotic drugs
- •Pregnant or breast-feeding women
- •Patients treated with sulforaphane for more than 8-weeks in the past.
研究组 & 干预措施
A single-arm study
干预措施: Sulforaphane-rich Broccoli Sprout Extract (Dietary Supplement)
结局指标
主要结局
Positive and Negative Syndrome Scale (PANSS)
时间窗: Change from baseline in PANSS scores at 8-weeks
次要结局
- Cognition using CogState Research Battery(Change from baseline in the scores of the battery at 8-weeks)
研究者
Kenji Hashimoto
Sulforaphane for Schizophrenia
Chiba University
